All data are based on the daily closing price as of November 12, 2026
g
GemVax&KAEL
082270.KQ
6.12 USD
0.04
+0.66%
Overview
Last close
6.12 usd
Market cap
218.22M usd
52 week high
51.11 usd
52 week low
6.04 usd
Target price
N/A usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
4.0816
Price/Book Value
4.9627
Enterprise Value
305.87M usd
EV/Revenue
4.7884
EV/EBITDA
28.168
Key financials
Revenue TTM
59.21M usd
Gross Profit TTM
14.01M usd
EBITDA TTM
1.73M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
105.40M usd
Net debt
36.85M usd
About
GemVax&KAEL Co.,Ltd engages in the manufacturing and commercializing of resins and filters for semi-conductor and panel display production in South Korea. The company offers impregnated active carbon and inorganic adsorbent coating resins; CA filter for removing chemical pollution substances and harmful gases in semiconductor and LCD/PDP manufacturing process; adsorbent towers for air pollution prevention; and pressure facility for preventing equipment erosion within a substation; and 5aver, a fire evacuation mask. It also engages in the research and development of anti-cancer immunotherapeutic and peptide drugs; and provides RIAVAX, an immunotherapeutic peptide for the treatment of locally advanced or metastatic pancreatic cancer. The company was founded in 1998 and is headquartered in Daejeon, South Korea.